Dermatofibrosarcoma protuberans of the vulva: margins assessment and reconstructive options – a report of two cases by Eduardo Bertolli et al.
WORLD JOURNAL OF 
SURGICAL ONCOLOGY
Bertolli et al. World Journal of Surgical Oncology 2015, 12:399
http://www.wjso.com/content/12/1/399CASE REPORT Open AccessDermatofibrosarcoma protuberans of the vulva:
margins assessment and reconstructive options –
a report of two cases
Eduardo Bertolli1*, Eduard Renè Bretchbuhl1, William Ricardo Camarço1, Mariane Campagnari1, André Sapata Molina1,
Glauco Baiocchi2, Mariana Petaccia de Macedo3, Clovis Antonio Lopes Pinto3, Isabela Werneck da Cunha3
and João Pedreira Duprat Neto1Abstract
Background: Dermatofibrosarcoma Protuberans (DFSP) of the vulva is rare and oncologic surgery with free margins
may lead to severe functional damage, requiring multidisciplinary approach regarding resection, margin assessment
and reconstruction.
Case Report: Two cases of DFSP in vulva were treated in a single institution. A 28-year-old patient with an incisional
biopsy in the vulvar region revealing DFSP underwent a partial vulvectomy with clitoris preservation. Pathological studies
revealed free margins and reconstructive surgery was performed. This patient is disease free in a 40 months follow up.
The other, a 57-year-old patient was also referred after an incomplete resection of a DFSP in the vulvar region. A 1-cm
margim resection followed by Complete Circumferential and Peripheral Deep Margin Assessment (CCPDMA) was
performed. Although the upper lateral margin was positive, it was possible to perform another wide local excision with
preservation of the clitoris and primary closure.
Conclusion: DFSP of the vulva requires an accurate evaluation of margins, resections following oncological principles
and reconstruction. Although being a very challenging lesion that usually implies difficult surgical management, if
treated in a multidisciplinary environment, with surgical oncologists, experienced dermatopathologists and
reconstructive surgeons can achieve good results. Even in difficult cases that presents with large lesions and
compromising challenging areas, a complete oncologic resection can be performed minimizing functional damage
for the patient.
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Dermatofibrosarcoma protuberans (DFSP) is a rare skin
mesenchymal tumor that usually affects the trunk and
extremities. Vulvar DFSP is rare, with fewer than 40
cases previously reported in the literature [1,2]. Surgery
has been reported as the main therapeutic option for
DFSP treatment. However, there is no consensus on
margin assessment protocols. The most frequently used
techniques are Mohs surgery, wide local excision (WLE)
with 2.0 or 3.0 cm margins and surgery followed by* Correspondence: ebertolli@hotmail.com
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unless otherwise stated.three-dimensional complete circumferential and peripheral
deep margin assessment (CCPDMA) [3-6].
The CCPDMA technique consists of excising the tumor
with a margin smaller than the traditional 3.0-cm one.
The specimen is submitted to conventional histologic
processing and margins are completely evaluated by the
pathologist. Additional study with immunohistochemistry
(IHC) may be useful for margin assessment in some
doubtful cases. This technique is associated with a more
accurate evaluation of the margins and literature reports
rates of recurrence lower than 10% [5,7].
Another very important aspect of surgery in vulvar
DFSP is the clitoris preservation and reconstruction after
the lesion is removed, because this directly affectsThis is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
Figure 1 Patient 1. (A) Clinical aspect of the residual lesion of dermatofibrosarcoma protuberans of the vulva before the surgery. (B) One year
after the first surgery, a skin expander was placed. (C) The expander was taken out and the inferior 2/3 of the flap was split. (D) the distal portion
was incised horizontally on both sides and folded after, in order to reconstruct the labius majoras. (E) Follow up after 8 weeks.
Figure 2 Patient 2: final clinical aspect of the second surgery
when primary closure was performed twice.
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results are achieved with a multidisciplinary approach.
The objective of this study was to present two cases of
vulvar DFSP managed by the Skin Cancer and Gynecology
Oncology Departments of AC Camargo Cancer Center
with minimal functional damage for the patient. This case
report was approved for publication by Fundação Antonio
Prudente ethics committee.
Case presentation
The first case is a 28-year-old female patient referred to us
after an incisional biopsy in the vulvar region revealing
DFSP. She presented to us with a 5.0-cm lesion in the
mons pubis (Figure 1A). Surgery was indicated, and con-
sisted of a vulvectomy with a local advancement flap as
the first approach in order to obtain a 2.0 cm margin from
the tumor. Margins were assessed by CCPDMA protocols
and they were all free of disease. Therefore, it was possible
to avoid clitoris resection.
To perform the vulvar reconstruction, a skin expander
was placed in the inferior part of the abdominal wall one
year after vulvectomy (Figure 1B). Weekly expansion was
performed 3 weeks after the procedure and, in the third
month, sufficient skin was attained in this area. The
expander was taken out and the inferior 2/3 of the flap
was split. The skin of the mons pubis was decorticated
and the medium and proximal portions of the flap were
advanced to protect the pubis bone. The distal portion
was incised horizontally on both sides and folded after, in
order to reconstruct the labius majoras (Figure 1C and D).This patient has been followed for almost 40 months
(Figure 1E). There is no clinical or radiological evidence of
recurrence. Regarding the surgery, we considered that a
very adequate aesthetic effect was achieved. The patient
verbally reported good quality of life, although no quality
of life (QOL) questionnaires were applied.
The second case is a 57-year-old female patient, also
referred to our hospital after an incomplete resection of a
DFSP in the vulvar region. She presented to us with a 2.0 cm
residual lesion in the right labium major. As the lesion was
too close to the clitoris, we performed a 1.0-cm margin
Table 1 Summary of the reported cases of Dermatofibrosarcoma Protuberans of the vulva with clinical, treatment and
follow up information
Author Cases Age, years Clinical presentation Size, cm Initial treatment Outcome/follow up
Edelweiss and
Malpica [1]
1 36 Right labium major
mass
5 Excisional biopsy LR at 12 months. AWD at 16 months
Edelweiss and
Malpica [1]
2 57 Right labium major
mass
3 Excisional biopsy LR at 60 months, then WLE (2x) until
negative margin. NED at 216 months.
Edelweiss and
Malpica [1]
3 69 Mons pubis mass 3 Excisional biopsy +WLE Dead of other causes at 144 months
Edelweiss and
Malpica [1]
4 48 Left paraclitoral mass 1.2 Excisional biopsy +WLE LR, then WLE. NED at 144 months.
Edelweiss and
Malpica [1]
5 46 Right labium major
pigmented lesion
4 Excisional biopsy +
WLE (x2)
NED at 84 months.
Edelweiss and
Malpica [1]
6 76 Right labium major
and crural fold mass
15 Excisional biopsy +WLE LR at 7 months, then WLE with negative
margin. At 14 months, metastasis to chest
wall. At 18 months, metastasis to hip and
thigh. Death of the disease at 34 months.
Edelweiss and
Malpica [1]
7 44 Left labium major
mass
4 Excisional biopsy +WLE NED at 53 months
Edelweiss and
Malpica [1]
8 39 Right labium major
mass
N/A WLE LR at 48 months. Then, WLE with positive
margin. At 60 months, local recurrence.
Then WLE with positive margin. Used Gleevec.
NED at 72 months
Edelweiss and
Malpica [1]
9 30 Right labium major
and mons pubis mass
N/A Excisional biopsy +
WLE




10 23 Right labium major
mass
4 Excisional biopsy +
WLE
NED at 2 months
Edelweiss and
Malpica [1]
11 30 Left labium major
mass
N/A Excisional biopsy LR at 60 months followed by WLE with
positive margin. Then, partial vulvectomy
with negative margin. NED at 96 months
Edelweiss and
Malpica [1]
12 44 Right labium major
mass
2.5 Excisional biopsy +
radical vulvectomy
NED at 36 months
Edelweiss and
Malpica [1]
13 58 Paraclitoral mass
extending into vagina
4.8 WLE NED at 3 months
Soltan [10] 14 83 Left labium major/
minor nodule
5 Excisional biopsy N/A
Agress et al.
[11]
15 56 Left labium major N/A Excisional biopsy LR, then WLE
Bock et al. [12] 16 52 Right mons pruritus 8 Excisional biopsy LR, then WLE
Barnhill et al.
[13]
17 42 Right vulva lateral to
clitoris nodule
1 Excisional biopsy LR, then WLE and hemivulvectomy
Leake et al. [14] 18 37 Left mons and labium
major nodule
6.2 Excisional biopsy LR, then wide radical excision
Leake et al. [14] 19 59 Right labium major
nodule
5 Excisional biopsy LR, then partial radical vulvectomy
Panidis et al.
[15]
20 30 Right labium major
nodule




21 50 N/A 1.2 Radical vulvectomy N/A
Karlen et al.
[17]










24 58 Left labium major
mass
3.2 WLE N/A
25 47 3 LR, then WLE + radiotherapy
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Table 1 Summary of the reported cases of Dermatofibrosarcoma Protuberans of the vulva with clinical, treatment and
follow up information (Continued)
Soergel et al.
[20]







26 47 Left paraclitoral area N/A Hemivulvectomy LR, then wide radical excision
Ghorbani et al.
[21]
27 44 Left labium major mass 4 Wide radical excision N/A
Ghorbani et al.
[21]
28 66 Mons mass 1.5 WLE N/A
Ghorbani et al.
[21]
29 36 Right labium mass 5 Excsional biopsy N/A
Moodley and
Moodley [22]
30 39 Left labium major mass 12 WLE N/A





32 31 Left labium major
recurrent nodule
1.5 Excisional biopsy LR, then WLE + radiotherapy
Ohlinger et al.
[25]
33 36 Left vulva nodule 2.8 Excisional biopsy LR, then WLE
Hancox et al.
[26]










36 39 Left labium major
nodule
N/A Incisional biopsy MMS with primary closure.




37 66 Mons pubis N/A WLE NED
N/A, not available; WLE, wide local excision; MMS, Mohs micrographic surgery; LR, local recurrence; AWD, alive with disease; AWOD, alive without disease; NED,
no evidence of disease).
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closure. The CCPDMA revealed all positive margins except
for the upper lateral region of the specimen. The patient was
submitted to another WLE of 2.0 cm and subsequent pri-
mary closure could be performed once more (Figure 2A).
This patient has been followed for 10 months without any
aesthetic or functional issue related to the surgery.
Conclusion
Regardless being a very rare disease, DFSP in the vulva rep-
resents a very challenging situation for the oncologic and
plastic surgeons. The resection must follow oncological
principles, which sometimes may lead to several aesthetic
and functional impacts for the patient due to the difficulty
in planning how wide the resection should be [4]. In this
context, reconstructive surgery plays a fundamental role in
the management of DFSP patients.
There are just few cases of vulvar DFSP reported in the
literature. See Table 1 for a summary of previously re-
ported cases of DFSP in the vulva with clinical, treatment
and follow-up information. The largest series, from the
MD Anderson Cancer Center, reported 13 cases. All of
the six cases with positive margins after resectiondeveloped tumor recurrence. There was only one relapse
between the cases with negative margins after WLE that
occurred in a patient showing fibrosarcomatous trans-
formation in the recurrent tumor [1].
Based on this paper, the role of an adequate assessment
of margins in these cases can be assumed. In our service,
the protocol is to submit the specimen to conventional
histologic processing with complete evaluation of the mar-
gins by CCPDMA by the pathologist, and IHC study
whenever necessary [2,5]. The morphologic and molecular
pathologic findings of vulvar DFSP are quite similar to
DFSP in other sites, including the frequent finding of the
fusion between collagen type I alpha 1 gene (COL1A1) on
chromosome 17 and the platelet-derived growth factor
B-chain (PDGFB) gene on chromosome 22 [23,28].
There is also scarce literature on reconstructive options
in vulvar DFSP. There are two recent reports on Mohs
surgery for vulvar DFSP, and both were submitted to pri-
mary closure [3,6]. No data related to clitoris preservation
or major vulvar reconstructions have been found.
Skin expansions are often used to reconstruct burned
areas or breasts after a mastectomy or to hide scars [29].
Although there is no strong evidence in the literature to
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safely used since the tumor resection is not delayed
because of the use of the expansion. Also, in our case we
have had a very rigorous assessment of the pathological
margins to ensure that the resection was complete. More-
over, the patient was kept for over a year in clinical follow
up before starting the expansion.
Our first case illustrates an example of a major vulvar
reconstruction using skin expansion followed by a skin
and fat tissue flap. Although it has been done in only
one patient, the clinical outcome suggests this can be a
feasible option in such cases. Both our patients were
submitted to clitoris-sparing surgery, which was only
possible due to the utilization of the CCPDMA protocol
by our Pathology Department.
We conclude that vulvar DFSP, although a very chal-
lenging lesion that usually implies difficult surgical man-
agement, if treated in a multidisciplinary environment
with surgical oncologists, experienced pathologists and
reconstructive surgeons, can achieve good results. And
even in difficult cases that present with large lesions and
compromising challenging areas, a complete oncologi-
cresection can be performed, minimizing functional
damage for the patient.
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